Work Absence Following COVID-19 Vaccination in a Cohort of Healthcare Personnel.
J Occup Environ Med
; 64(1): 6-9, 2022 01 01.
Article
in English
| MEDLINE | ID: covidwho-1604008
ABSTRACT
OBJECTIVE:
To identify rates of work absence following receipt of COVID-19 vaccine in a cohort of healthcare personnel (HCP).METHODS:
Short-term disability (STD) usage by HCP attributed to side effects of the COVID-19 vaccine was calculated for each vaccine manufacturer, job category, age group, and work region. Analysis was performed for the cohort of HCP during the initial vaccination campaign.RESULTS:
4.1% of COVID-19 vaccinations generated a STD claim for lost work due to side effects, with increased STD rates after dose 2 than dose 1 (7.4% and 0.9%, respectively). Rates were higher for younger HCP and allied health staff.CONCLUSIONS:
While side effects from mRNA vaccine dose 2 resulted in more work absence, statistically significant geographic differences in STD suggest cultural and staffing factors may impact HCP to utilize STD following vaccination.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Occup Environ Med
Journal subject:
Occupational Medicine
/
Environmental Health
Year:
2022
Document Type:
Article
Affiliation country:
JOM.0000000000002376
Similar
MEDLINE
...
LILACS
LIS